CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 104 filers reported holding CULLINAN ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,023,660 | -28.8% | 60,074 | -57.4% | 0.01% | -30.0% |
| Q4 2023 | $1,436,790 | +30.3% | 141,000 | +15.8% | 0.01% | +11.1% |
| Q3 2023 | $1,102,290 | -2.5% | 121,800 | +15.9% | 0.01% | -10.0% |
| Q2 2023 | $1,130,876 | +221.4% | 105,100 | +205.5% | 0.01% | +233.3% |
| Q1 2023 | $351,912 | -1.9% | 34,400 | +1.2% | 0.00% | 0.0% |
| Q4 2022 | $358,700 | -55.7% | 34,000 | -5.2% | 0.00% | -62.5% |
| Q3 2021 | $809,000 | -59.9% | 35,858 | -25.9% | 0.01% | -68.0% |
| Q1 2021 | $2,017,000 | – | 48,373 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,913,887 | $203,783,000 | 33.48% |
| Foresite Capital Management V, LLC | 2,731,410 | $70,334,000 | 27.67% |
| CHI Advisors LLC | 2,242,841 | $57,753,000 | 13.44% |
| VR Adviser, LLC | 976,145 | $25,136,000 | 3.05% |
| Boxer Capital, LLC | 1,074,082 | $27,658,000 | 0.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 75,732 | $1,950,000 | 0.87% |
| BVF INC/IL | 735,106 | $18,929,000 | 0.71% |
| Birchview Capital, LP | 45,114 | $1,162,000 | 0.70% |
| Logos Global Management LP | 288,458 | $7,428,000 | 0.62% |
| Ikarian Capital, LLC | 295,596 | $7,613,000 | 0.62% |